CAMP logo

CAMP4 Therapeutics Corporation

CAMP
Healthcare|Biotechnology|US
$4.06
+0.34 (+9.14%)
Tangible Book / Share
$1.36
Cash / Share
$1.58
Next Earnings Report
Mar 4, 2027
EPS est. -$0.20 · Revenue est. $1.7M
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Aug 12, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (1)

Dec 2027
Est. completion
P1Healthy Volunteers
Study of CMP-CPS-001 in Healthy Volunteers and Participants With Abnormal Heterozygous OTC Genotype
NCT06247670n=120

Recent Press Releases

CAMP4 Reports Third Quarter 2026 Financial Results and Corporate Highlights
Nov 5, 2026 · GlobeNewsWire
CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union
Oct 27, 2026 · GlobeNewsWire
CAMP4 to Participate in Chardan's 10th Annual Healthcare Conference
Oct 14, 2026 · GlobeNewsWire
CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder
Sep 10, 2026 · GlobeNewsWire
CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026
Sep 8, 2026 · GlobeNewsWire
CAMP4 to Participate in Upcoming Investor Conferences
Sep 1, 2026 · GlobeNewsWire
CAMP4 Reports Second Quarter 2026 Financial Results and Corporate Highlights
Aug 13, 2026 · GlobeNewsWire

SEC Filings (75)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 202610-QQuarterly reportDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Nov 5, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Sep 28, 20268-KMaterial eventDocumentIndex
Aug 31, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 19, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Aug 12, 2026EFFECTDocumentIndex
Aug 12, 2026424B3Offering prospectusDocumentIndex
Aug 10, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 6, 2026S-3Shelf registrationDocumentIndex
Aug 5, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 4, 20268-KMaterial eventDocumentIndex
Jul 27, 20268-KMaterial eventDocumentIndex
Jun 12, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 14, 20268-KMaterial eventDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
May 7, 20268-KMaterial eventDocumentIndex
Apr 23, 2026ARSAnnual report to holdersDocumentIndex
Apr 23, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 23, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 24, 20268-KMaterial eventDocumentIndex
Mar 11, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Mar 5, 2026S-8Employee stock planDocumentIndex
Mar 5, 202610-KAnnual reportDocumentIndex
Mar 5, 20268-KMaterial eventDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 5, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 9, 20268-KMaterial eventDocumentIndex
Jan 8, 2026SC 13GPassive 5%+ stakeDocumentIndex
Dec 23, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Dec 23, 20258-KMaterial eventDocumentIndex
Dec 18, 20258-KMaterial eventDocumentIndex
Dec 18, 2025424B5Offering prospectusDocumentIndex
Dec 18, 2025FWPDocumentIndex
Dec 18, 20258-KMaterial eventDocumentIndex
Dec 11, 2025SC 13G/APassive 5%+ stakeDocumentIndex